Formulations:
- Oral > Solid: 15 mg tablet
Parenteral > General injections > unspecified: 3 mg per mL in 10 mL ampoule
Parenteral > General injections > unspecified: 3 mg per mL in 10 mL ampoule; 7.5 mg per mL in 2 mL ampoule; 10 mg per mL in 5 mL ampoule
Oral > Solid > tablet: 15 mg; 5 mg; 25 mg
Indications:
- Unspecified malignant neoplasms of ill-defined or unspecified sites
- Malignant neoplasm metastasis in large intestine
- Burkitt lymphoma including Burkitt leukaemia
- Malignant trophoblastic neoplasms of placenta
- Osteosarcoma of bone and articular cartilage of unspecified sites
- Malignant neoplasms of rectum
- Malignant neoplasms of colon
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Formulations:
- Oral > Solid: 15 mg tablet
Parenteral > General injections > unspecified: 3 mg per mL in 10 mL ampoule
Parenteral > General injections > unspecified: 3 mg per mL in 10 mL ampoule; 7.5 mg per mL in 2 mL ampoule; 10 mg per mL in 5 mL ampoule
Oral > Solid > tablet: 15 mg; 5 mg; 25 mg
Indications:
- Unspecified malignant neoplasms of ill-defined or unspecified sites
- Malignant neoplasm metastasis in large intestine
- Burkitt lymphoma including Burkitt leukaemia
- Malignant trophoblastic neoplasms of placenta
- Osteosarcoma of bone and articular cartilage of unspecified sites
- Malignant neoplasms of rectum
- Malignant neoplasms of colon
Source: EML workbook import